相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review
Ragy R. Girgis et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
N-methyl-D-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia
Joshua T. Kantrowitz
SCHIZOPHRENIA RESEARCH (2019)
The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
Andrew D. Krystal et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation
William R. Kem et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Efficacy and Safety of the alpha(7)-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers
George M. Haig et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders A Randomized Clinical Trial
Daniel C. Javitt et al.
JAMA PSYCHIATRY (2018)
The effects of glycine on auditory mismatch negativity in schizophrenia
Lisa-Marie Greenwood et al.
SCHIZOPHRENIA RESEARCH (2018)
A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia
Migyung Lee et al.
SCHIZOPHRENIA RESEARCH (2018)
Improvement in mismatch negativity generation during D-serine treatment in schizophrenia: Correlation with symptoms
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2018)
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
Kelvin W. Gee et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies
Alan S. Lewis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia
Michael L. Thomas et al.
JAMA PSYCHIATRY (2017)
Managing Negative Symptoms of Schizophrenia: How Far Have We Come?
Joshua T. Kantrowitz
CNS DRUGS (2017)
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
David Walling et al.
SCHIZOPHRENIA BULLETIN (2016)
A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia
George M. Haig et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine
Joshua T. Kantrowitz et al.
BRAIN (2016)
Derisking Psychiatric Drug Development The NIMH's Fast Fail Program, A Novel Precompetitive Model
Margaret C. Grabb et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia
Daniel C. Javitt et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Social cognition in schizophrenia
Michael F. Green et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
Richard S. E. Keefe et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Functional and Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia A Functional Magnetic Resonance Imaging Study of the Relational and Item-Specific Encoding Task
J. Daniel Ragland et al.
JAMA PSYCHIATRY (2015)
Understanding the Role α7 Nicotinic Receptors Play in Dopamine Efflux in Nucleus Accumbens
Reinoud Maex et al.
ACS CHEMICAL NEUROSCIENCE (2014)
alpha 7-Nicotinic Acetylcholine Receptor Agonists for Cognitive Enhancement in Schizophrenia
Robert Freedman
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition: A Proof of Concept, Randomized Trial in Patients with Schizophrenia
Sheldon H. Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2014)
A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
Daniel Umbricht et al.
NEUROPSYCHOPHARMACOLOGY (2014)
The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens
Mei Huang et al.
PSYCHOPHARMACOLOGY (2014)
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
Georg Winterer et al.
NEUROPHARMACOLOGY (2013)
A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
Jeffrey A. Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Auditory Emotion Recognition Impairments in Schizophrenia: Relationship to Acoustic Features and Cognition
Rinat Gold et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
From Perception to Functional Outcome in Schizophrenia Modeling the Role of Ability and Motivation
Michael F. Green et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Neural correlates of relational and item-specific encoding during working and long-term memory in schizophrenia
John D. Ragland et al.
NEUROIMAGE (2012)
Relational and Item-Specific Encoding (RISE): Task Development and Psychometric Characteristics
John D. Ragland et al.
SCHIZOPHRENIA BULLETIN (2012)
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
Suzie Lavoie et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Nootropic α7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators
Herman J. Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia
David Potter et al.
SCHIZOPHRENIA BULLETIN (2006)
Genetics of chromosome 15q13-q14 in schizophrenia
Sherry Leonard et al.
BIOLOGICAL PSYCHIATRY (2006)
Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia
Ann Olincy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: A 1-and 4-year prospective study
MM Kurtz et al.
SCHIZOPHRENIA BULLETIN (2005)
Dopamine D2 receptors and their role in atypical antipsychotic action:: Still necessary and may even be sufficient
S Kapur et al.
BIOLOGICAL PSYCHIATRY (2001)
A separate disease within the syndrome of schizophrenia
B Kirkpatrick et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
分享论文
